Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: Key messages from Disease Control Priorities, 3rd edition

The Lancet

Volumn 387, Issue 10033, 2016, Pages 2133-2144

  Gelband, Hellen ^a   Sankaranarayanan, Rengaswamy ^b   Gauvreau, Cindy L ^c   Horton, Susan ^e   Anderson, Benjamin O ^f   Bray, Freddie ^b   Cleary, James ^g   Dare, Anna J ^c   Denny, Lynette ^h   Gospodarowicz, Mary K ⁱ   Gupta, Sumit ^j   Howard, Scott C ^k   Jaffray, David A ⁱ   Knaul, Felicia ^l   Levin, Carol ^m   Rabeneck, Linda ⁿ   Rajaraman, Preetha ^o   Sullivan, Terrence ^d   Trimble, Edward L ^o   Jha, Prabhat ^c  

^a Centre for Disease Dynamics Economics and Policy   (United States)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF WATERLOO   (Canada)

^f Fred Hutchinson Cancer Research Center   (United States)

^g UNIVERSITY OF WISCONSIN MADISON   (United States)

^h UNIVERSITY OF CAPE TOWN   (South Africa)

ⁱ PRINCESS MARGARET HOSPITAL   (Canada)

^j HOSPITAL FOR SICK CHILDREN   (Canada)

^k UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^l HARVARD UNIVERSITY   (United States)

^m UNIVERSITY OF WASHINGTON   (United States)

ⁿ CANCER CARE ONTARIO   (Canada)

^o NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

AFFORDABILITY; BREAST CANCER; CANCER CONTROL; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER PREVENTION; CANCER SCREENING; CANCER THERAPY; CHILDHOOD CANCER; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH CARE PLANNING; HEALTH PROGRAM; HEALTH SERVICE; HOUSEHOLD; HUMAN; INTERVENTION STUDY; LIVER CANCER; LOWEST INCOME GROUP; MIDDLE INCOME; NEOPLASM; POVERTY; PRIORITY JOURNAL; PROGRAM COST EFFECTIVENESS; PROGRAM FEASIBILITY; REVIEW; SOCIAL STATUS; SOCIOECONOMICS; SYSTEMATIC REVIEW (TOPIC); UTERINE CERVIX CANCER; DEVELOPING COUNTRY; ECONOMICS; HEALTH; HEALTH CARE DELIVERY; INCOME; MORTALITY; NEOPLASMS; STATISTICS AND NUMERICAL DATA;

DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; GLOBAL HEALTH; HUMANS; INCOME; NEOPLASMS;

EID: 84949024349     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)00755-2     Document Type: Review

References (89)

1. UN Department of Economics and Social Affairs Transforming our world: the 2030 Agenda for Sustainable Development https://sustainabledevelopment.un.org/post2015/transformingourworld (accessed Oct 31, 2015).
2. OF Norheim, P Jha, K Admasu et al. Avoiding 40% of the premature deaths in each country, 2010-30: review of national mortality trends to help quantify the UN Sustainable Development Goal for health Lancet 385 2015 239 252
3. DT Jamison Disease Control Priorities, 3rd edition: improving health and reducing poverty Lancet 2015 published online Feb 4. http://dx.doi.org/10.1016/S0140-6736(15)60097-6
4. DT Jamison, LH Summers, G Alleyne et al. Global health 2035: a world converging within a generation Lancet 382 2013 1898 1955
5. ML Brown, SJ Goldie, G Draisma et al. Health service interventions for cancer control in developing countries DT Jamison J Breman AR Measham Disease control priorities in developing countries 2nd edn. 2006 Oxford University Press New York 569 589
6. FM Knaul, JR Gralow, R Atun et al. Closing the cancer divide: an equity imperative 2011 Harvard Global Equity Initiative and Harvard University Press Cambridge, MA
7. FA Sloan, H Gelband Cancer control opportunities in low- and middle-income countries 2007 National Academy Press Washington, DC
8. FM Knaul, E González-Pier, O Gómez-Dantés et al. The quest for universal health coverage: achieving social protection for all in Mexico Lancet 380 2012 1259 1279
9. WHO Health statistics and information systems: global health estimates http://www.who.int/gho/mortality-burden-disease/en/ 2012 (accessed Oct 31, 2015).
10. UNPD World population prospects: the 2012 revision 2012 UN Population Division New York
11. World Bank World Bank development indicators 2014: table 2.15 health systems http://wdi.worldbank.org/table/2.15 (accessed May 31, 2015).
12. C Allemani, HK Weir, H Carreira the CONCORD Working Group Global surveillance of cancer survival 1995-2009: analysis of individual data for 25676887 patients from 279 population-based registries in 67 countries (CONCORD-2) Lancet 385 2015 977 1010
13. J Ferlay, I Soerjomataram, R Dikshit et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 2015 e359 e386
14. F Bray, I Soerjomataram Chapter 2. The changing global burden of cancer H Gelband P Jha R Sankaranarayanan S Horton 3rd edn. Disease control priorities, cancer Volume 3 2015 World Bank Washington, DC (in press).
15. P Jha Avoidable global cancer deaths and total deaths from smoking Nat Rev Cancer 9 2009 655 664
16. R Dikshit, PC Gupta, C Ramasundarahettige the million Death Study Collaborators Cancer mortality in India: a nationally representative survey Lancet 379 2012 1807 1816
17. SA Hamid, SM Ahsan, A Begum Disease-specific impoverishment impact of out-of-pocket payments for health care: evidence from rural Bangladesh Appl Health Econ Health Policy 12 2014 421 433
18. N Hoang Lan, W Laohasiriwong, JF Stewart, ND Tung, PC Coyte Cost of treatment for breast cancer in central Vietnam Glob Health Act 6 2013 18872
19. AM Ilbawi, EM Einterz, D Nkusu Obstacles to surgical services in a rural Cameroonian district hospital World J Surg 37 2013 1208 1215
20. RM John, HY Sung, WB Max, H Ross Counting 15 million more poor in India, thanks to tobacco Tob Control 20 2011 349 352
21. MK Mallath, DG Taylor, RA Badwe et al. The growing burden of cancer in India: epidemiology and social context Lancet Oncol 15 2014 e205 e212
22. WHO Macroeconomics and health: investing in health for economic development 2001 World Health Organization Geneva
23. WHO Scaling up action against non-communicable diseases: how much will it cost? 2011 World Health Organization Geneva
24. BO Anderson, J Lipscomb, RH Murillo et al. Chapter 3. Breast cancer H Gelband P Jha R Sankaranarayanan S Horton 3rd edn. Disease control priorities, cancer Volume 3 2015 World Bank Washington, DC (in press).
25. S Gupta, SC Howard, SP Hunger et al. Chapter 7. Childhood cancers H Gelband P Jha R Sankaranarayanan S Horton 3rd edn. Disease control priorities, cancer Volume 3 2015 World Bank Washington, DC (in press).
26. J Cleary, H Gelband, J Wagner Chapter 9. Cancer pain relief H Gelband P Jha R Sankaranarayanan S Horton 3rd edn. Disease control priorities, cancer Volume 3 2015 World Bank Washington, DC (in press).
27. BO Anderson, E Cazap, NS El Saghir et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010 Lancet Oncol 12 2011 387 398
28. KM Foley, JL Wagner, DE Joranson, H Gelband Pain control for people with cancer and AIDS DT Jamison J Breman AR Measham Disease control priorities in developing countries 2nd edn. 2006 World Bank Washington, DC 981 993
29. WHO Immunization Practices Advisory Committee Final meeting report and recommendations, 12-13 April, 2011 http://www.who.int/immunization/policy/committees/IPAC-2011-April-report.pdf?ua=1 (accessed May 31, 2015).
30. Gavi the vaccine alliance Millions of girls in developing countries to be protected against cervical cancer thanks to new HPV vaccine deals http://www.gavi.org/library/news/press-releases/2013/hpv-price-announcement/ 2013 (accessed May 31, 2015).
31. L Denny, R Herrero, C Levin et al. Cervical cancer. Chapter 4 H Gelband P Jha R Sankaranarayanan S Horton 3rd edn. Disease control priorities, cancer Volume 3 2015 World Bank Washington, DC (in press).
32. P Jha, R Peto Global effects of smoking, of quitting, and of taxing tobacco N Engl J Med 370 2014 60 68
33. Z Chen, R Peto, M Zhou for the China Kadoorie Biobank (CKB) collaborative group Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies Lancet 386 2015 1447 1456
34. WHO WHO report on the global tobacco epidemic 2013 2013 World Health Organization Geneva
35. C Van Walbeek Tobacco control in South Africa Promot Educ 12 suppl 4 2005 25 28 (in French).
36. C Hill Impact de l'augmentation des prix sur la consummation de tabac 2013 Institut Gustave Roussy Paris http://www.igr.fr/doc/cancer/pdf/prevention/prixtab2013.pdf (acessed May 31, 2015).
37. CA Monteiro, TM Cavalcante, EC Moura, RM Claro, CL Szwarcwald Population-based evidence of a strong decline in the prevalence of smokers in Brazil (1989-2003) Bull World Health Organ 85 2007 527 534
38. P Jha, M MacLennan, A Yurekli et al. Chapter 10. Global hazards of tobacco, benefits of cessation and of taxation of tobacco H Gelband P Jha R Sankaranarayanan S Horton 3rd edn. Disease control priorities, cancer Volume 3 2015 World Bank Washington, DC (in press).
39. P Jha Deaths and taxes: stronger global tobacco control by 2025 Lancet 385 2015 918 920
40. T Sullivan, R Sullivan, OM Ginsburg Chapter 12. Screening for cancer: considerations for LMICs H Gelband P Jha R Sankaranarayanan S Horton 3rd edn. Disease control priorities, cancer Volume 3 2015 World Bank Washington, DC (in press).
41. PE Goss, BL Lee, T Badovinac-Crnjevic et al. Planning cancer control in Latin America and the Caribbean Lancet Oncol 14 2013 391 436
42. R Sankaranarayanan, BM Nene, SS Shastri et al. HPV screening for cervical cancer in rural India N Engl J Med 360 2009 1385 1394
43. SJ Goldie, L Gaffikin, JD Goldhaber-Fiebert the Alliance for Cervical Cancer Prevention Cost Working Group Cost-effectiveness of cervical-cancer screening in five developing countries N Engl J Med 353 2005 2158 2168
44. US Preventive Services Task Force Final recommendation statement. Prostate cancer: screening http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/prostate-cancer-screening May 2012 (accessed May 31, 2015).
45. L Rabeneck, S Horton, AG Zauber et al. Chapter 6. Colorectal cancer H Gelband P Jha R Sankaranarayanan S Horton 3rd edn. Disease control priorities, cancer Volume 3 2015 World Bank Washington, DC (in press).
46. R Sankaranarayanan, K Ramadas, H Amarasinghe et al. Chapter 5. Oral cancer H Gelband P Jha R Sankaranarayanan S Horton 3rd edn. Disease control priorities, cancer Volume 3 2015 World Bank Washington, DC (in press).
47. MK Gospodarowicz, J Trypuc, A D'Cruz et al. Chapter 11. Cancer services and the comprehensive cancer care center H Gelband P Jha R Sankaranarayanan S Horton 3rd edn. Disease control priorities, cancer Volume 3 2015 World Bank Washington, DC (in press).
48. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) R Peto, C Davies, J Godwin et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100000 women in 123 randomised trials Lancet 379 2012 432 444
49. AJ Dare, BO Anderson, R Sullivan et al. Chapter 13. Surgical services for cancer care H Gelband P Jha R Sankaranarayanan S Horton 3rd edn. Disease control priorities, cancer Volume 3 2015 World Bank Washington, DC (in press).
50. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials Lancet 386 2015 1341 1352
51. P Piot, TC Quinn Response to the AIDS pandemic - a global health model N Engl J Med 368 2013 2210 2218
52. MA Smith, NL Seibel, SF Altekruse et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century J Clin Oncol 28 2010 2625 2634
53. S Gupta, R Rivera-Luna, RC Ribeiro, SC Howard Pediatric oncology as the next global child health priority: the need for national childhood cancer strategies in low- and middle-income countries PLoS Med 11 2014 e1001656
54. MJ Seya, SF Gelders, OU Achara, B Milani, WK Scholten A first comparison between the consumption of and the need for opioid analgesics at country, regional, and global levels J Pain Palliat Care Pharmacother 25 2011 6 18
55. JD Groopman, TW Kensler, CP Wild Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries Annu Rev Public Health 29 2008 187 203
56. H Gelband, C-J Chen, W Chen et al. Chapter 8. Liver cancer H Gelband P Jha R Sankaranarayanan S Horton 3rd edn. Disease control priorities, cancer Volume 3 2015 World Bank Washington, DC (in press).
57. IARC IARC mongraphs on the evaluation of carcinogenic risks to humans: volume 61, Schistosomes, liver flukes and Helicobacter pylori 1994 International Agency for Research on Cancer Lyon
58. IARC IARC Mongraphs on the evaluation of carcinogenic risks to humans: volume 100 2012 International Agency for Research on Cancer Lyon
59. S Horton, CL Gauvreau Chapter 16. Cancer in low- and middle-income countries: an economic overview H Gelband P Jha R Sankaranarayanan S Horton 3rd edn. Disease control priorities, cancer Volume 3 2015 World Bank Washington, DC (in press).
60. S Ozawa, A Mirelman, ML Stack, DG Walker, OS Levine Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review Vaccine 31 2012 96 108
61. M Rodgers, M Soares, D Epstein, H Yang, D Fox, A Eastwood Bevacizumab in combination with a taxane for the first-line treatment of HER2-negative metastatic breast cancer Health Technol Assess 15 suppl 1 2011 1 12
62. KJ Dedes, K Matter-Walstra, M Schwenkglenks et al. Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: an economic evaluation Eur J Cancer 45 2009 1397 1406
63. AJ Montero, K Avancha, S Glück, G Lopes A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancer Breast Cancer Res Treat 132 2012 747 751
64. P Tappenden, R Jones, S Paisley, C Carroll Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer Health Technol Assess 11 2007 1 128
65. U Ringborg, D Bergqvist, B Brorsson et al. The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of radiotherapy for cancer including a prospective survey of radiotherapy practice in Sweden 2001 - summary and conclusions Acta Oncol 42 2003 357 365
66. S Verguet, CL Gauvreau, S Mishra et al. The consequences of tobacco tax on household health and finances in rich and poor smokers in China: an extended cost-effectiveness analysis Lancet Glob Health 3 2015 e206 e216
67. ZA Bhutta, JK Das, A Rizvi the Lancet Nutrition Interventions Review Group the Maternal and Child Nutrition Study Group Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet 382 2013 452 477
68. S Rao Seshadri, P Jha, P Sati et al. Karnataka's roadmap to improved health: cost effective solutions to address priority diseases, reduce poverty and increase economic growth 2015 Azim Premji University Bangalore
69. OECD OECD health policy studies. Cancer care: assuring quality to improve survival 2013 Organization for Economic Co-operation and Development (OECD) Publishing Paris
70. IARC World cancer report 2014 BW Stewart, CP Wild World Cancer Report 2014 International Agency for Research on Cancer Geneva
71. F Knaul, S Horton, P Yerramilli et al. Chapter 17. Financing cancer care in low-resource settings H Gelband P Jha R Sankaranarayanan S Horton 3rd edn. Disease control priorities, cancer Volume 3 2015 World Bank Washington, DC (in press).
72. O Shisana, T Rehle, J Louw, N Zungu-Dirwayi, P Dana, L Rispel Public perceptions on national health insurance: moving towards universal health coverage in South Africa S Afr Med J 96 2006 814 818
73. P Jha, R Laxminarayan Choosing health: an entitlement for all Indians 2009 Centre for Global Health Research Delhi and Toronto
74. WHO The world health report 2000 - health systems: improving performance 2000 World Health Organization Geneva
75. P Musgrove Public and private roles in health: theory and financing patterns. Health, nutrition and population (hnp) discussion paper 1996 World Bank Washington, DC
76. DT Jamison, P Jha, V Malhotra et al. The 20th century transformation of human health: its magnitude and value B Lomborg how much have global problems cost the world? A scorecard from 1900-2050 2011 Cambridge University Press Cambridge, UK 207 246
77. CN Mock, P Donkor, A Gawande, DT Jamison, ME Kruk, HT Debas for the DCP3 Essential Surgery Author Group Essential surgery: key messages from Disease Control Priorities, 3rd edition Lancet 385 2015 2209 2219
78. AJ Dare, JS Ng-Kamstra, J Patra the million Death Study Collaborators Deaths from acute abdominal conditions and geographical access to surgical care in India: a nationally representative spatial analysis Lancet Glob Health 3 2015 e646 e653
79. Union for International Cancer Control (UICC) Global task force on radiotherapy for cancer control: secondary global task force on radiotherapy for cancer control http://gtfrcc.org/global-radio-therapy/ (accessed May 31, 2015).
80. DA Jaffray, MK Gospodarowicz Chapter 14. Radiation therapy for cancer H Gelband P Jha R Sankaranarayanan S Horton 3rd edn. Disease control priorities, cancer Volume 3 2015 World Bank Washington, DC (in press).
81. F Bray, A Znaor, P Cueva et al. Planning and developing population-based cancer registration in low- and middle-income settings 2014 International Agency for Research on Cancer (IARC) Technical Publications Geneva
82. M Hewitt, S Greenfield, E Stovall From cancer patient to cancer survivor: lost in transition 2005 Institute of Medicine and National Research Council Washington, DC
83. J Pontén, H-O Adami, R Bergstrom et al. Strategies for global control of cervical cancer Int J Cancer 60 1995 1 26
84. ML Metzger, SC Howard, LC Fu et al. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries Lancet 362 2003 706 708
85. CS Pramesh, RA Badwe, RK Sinha The national cancer grid of India Indian J Med Paediatr Oncol 35 2014 226 227
86. Institute for Health Metrics and Evaluation Financing global health 2012: the end of the golden age? 2012 Institute for Health Metrics and Evaluation Seattle
87. JW Peabody, MM Taguiwalo, DA Robalino, J Frenk Improving the quality of care in developing countries DT Jamison J Breman AR Measham Disease control priorities in developing countries 2nd edn. 2006 World Bank Washington, DC 1293 1307
88. H Varmus, EL Trimble Integrating cancer control into global health Sci Transl Med 3 2011 101 128
89. EL Trimble, P Rajaraman, A Chao et al. Chapter 15. Cancer research: the need for national commitment H Gelband P Jha R Sankaranarayanan S Horton 3rd edn. Disease control priorities, cancer Volume 3 2015 World Bank Washington, DC (in press).